The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion
Status
Conditions
Treatments
Details and patient eligibility
About
There is substantial evidence that women throughout life have significantly lower plasma levels of the antidiuretic hormone vasopressin (pAVP) compared to men. The importance of this is not yet fully elucidated, but in relation to the observations of lower pAVP levels, no significant difference in renal response parameters was found. This could be interpreted an increased renal sensitivity in females compared to males. The theory of increased renal sensitivity in females is supported by a few pharmacodynamic studies currently available on this topic. However none of the studies was designed with the purpose of investigate the gender difference.
The aim of this study is to investigate possible gender differences in the renal sensitivity to dDAVP and the effect of age on these differences. This will be done by low dose graded infusion of the synthetic AVP analog dDAVP.
Participants are 80 healthy volunteers equally distributed between four age groups, 8-10 years of age, 16-18 years of age, 25-40 years og age and 65+ years of age.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Healthy
- Normal clinical examination
- Normal residual urine measurements
- Normal urine dip stick
- Informed consent by participant or legal guardian
Exclusion criteria
- Smoking, alcohol or drug abuse
- Conditions of importance to the results (endocrinological, renal or cardial)
- Current or previous history of incontinence, bedwetting or nocturia
- Drug use of importance (diuretics, hormone replacement therapy, birth control pills, desmopressin)
- Pregnancy
- Allergy towards dDAVP/desmopressin
Trial design
Primary purpose
Allocation
Interventional model
Masking
64 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal